Learn More
Medchemexpress LLC MPT0G211 | 2151853-97-1 | 99.8% | 293.32 g/mol | C17H15N3O2 | 50MG

Supplier: Medchemexpress LLC HY12397650MG
MPT0G211 is a potent, orally active, and selective histone deacetylase 6 (HDAC6) inhibitor used in preclinical research. It penetrates the blood-brain barrier and has demonstrated neuroprotective effects, reduction of tau phosphorylation, and anticancer/anti-metastatic activity in published models.
- Potent HDAC6 inhibitor (IC50 = 0.291 nM)
- Highly selective for HDAC6 (>1,000-fold vs other HDAC isoforms)
- Orally active and brain-penetrant
- Demonstrated neuroprotective effects and reduced tau phosphorylation in preclinical models
- Shows anticancer and anti-metastatic activity in preclinical studies
- High purity for research use (99.79%)
- Molecular formula C17H15N3O2; molecular weight 293.32 g/mol
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.